Wednesday, May 8, 2024 5/8/2024

Characterizing novel Beta-lactamases from metagenomic samples: insights into the evolution of antimicrobial resistance from the environment towards human-associated pathogens

Award Number: R01AI160371
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

PROJECT SUMMARY ß-Lactamases are the most widespread resistance mechanism to ß-lactam antibiotics. Of particular concern are a group of ß-lactamases known as carbapenemases, named for their ability to destroy our newest ß-lactam antibiotics, the carbapenems. The rise of carbapenem resistance is a recent global trend that has resulted in pan-national fear. An interesting approach to understand carbapenem resistance and how it evolves is through quantitative analysis of non-pathogenic microorganisms found in the environment. Analysis of these microorganisms offers the intriguing possibility of predicting how antibiotic resistance may evolve and provides clinicians with an “early warning” system for the advent of novel resistance mechanisms in pathogenic bacteria. Previous research has shown that the soil is an excellent repository for many ß-lactamases, especially carbapenemases. The main part of the project will be the study of a collection of metagenome-origin ß-lactamases isolated from Alaskan soil, named LRA (for “ß-lactam resistance from Alaska”). This metagenomic approach will be expanded and applied to the analysis of soil samples from Antarctica to identify ß-lactamase-mediated resistance in different isolated regions. Identified environmental ß-lactamases will be characterized using a multi-pronged approach involving phenotypic, molecular, biochemical and structural techniques. Specifically, results from this comprehensive analysis will allow us to assess the evolutionary routes of ß-lactamases found among clinical pathogens that plague human health today, and to evaluate novel niches of potentially unexplored genes that could be recruited by these pathogens.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = $126,842 )
2023	2023	UBATEC SA	AVENIDA PRESIDENTE ROQUE SAENZ PENA 938 PISO: 6	CIUDAD AUTONOMA DE BUENOS AIRES				ARG	Allergy and Infectious Diseases Research	000	2	8/11/2023	NON-COMPETING CONTINUATION	$126,842
														Subtotal = $126,842

Issue Date FY: 2022 ( Subtotal = $127,728 )
2022	2022	UBATEC S.A.	AVENIDA PRESIDENTE ROQUE SAENZ PENA 938, PISO 6	CIUDAD DE BUENOS AIRES				ARG	Allergy and Infectious Diseases Research	000	1	9/21/2022	NEW	$127,728
														Subtotal = $127,728

Grand Total All Awards = $254,570

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Characterizing novel Beta-lactamases from metagenomic samples: insights into the evolution of antimicrobial resistance from the environment towards human-associated pathogens

Award Number: R01AI160371

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer